Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...51525354555657585960...
CompanyDrug NameStatusIndication Group
Genentech AVASTIN Approved in USAAntineoplastic & immunomodulating agents
Genentech AVASTIN accomplished Phase IIIAntineoplastic & immunomodulating agents
Genentech AVASTIN Approved in EUAntineoplastic & immunomodulating agents
Genentech AVASTIN Approved in USA, submitted for approval in EUAntineoplastic & immunomodulating agents
GlaxoSmithKline Avandia Approved in USAAlimentary tract & metabolism
GlaxoSmithKline Avandia Approved in EUAlimentary tract & metabolism
GlaxoSmithKline Avandia in Phase IIIDermatologicals
GlaxoSmithKline Avandia in Phase IINervous system
GlaxoSmithKline Avandia in Phase IIMusculoskeletal system
GlaxoSmithKline Avandaryl Avandia and Amaryl Approved in USA and EUAlimentary tract & metabolism
GlaxoSmithKline Avandamet XR in Phase IIIAlimentary tract & metabolism
GlaxoSmithKline Avandamet Approved in USAAlimentary tract & metabolism
GlaxoSmithKline Avamys/Alermist in Phase IIIRespiratory system
Bristol-Myers Squibb Avalide in Phase IIIAlimentary tract & metabolism
Bristol-Myers Squibb Avalide in Phase IIIAntineoplastic & immunomodulating agents
NeuTec Pharma Autograb accomplished Phase IIIAnti-infectives for systemic use
Dainippon Sumimoto Pharma Aurorix in Phase IINervous system
Inhibitex Aurexis accomplished Phase IIAnti-infectives for systemic use
GlaxoSmithKline Augmentin XR in Phase IAnti-infectives for systemic use
GlaxoSmithKline Augmentin once daily in Phase IAnti-infectives for systemic use
...51525354555657585960...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.